Rare diseases
Investigational molecules
Locations
Via Casilina 5, 00182 Rome, Italy
Research activity is centered on acute myeloid leukemia, including FLT3-mutated AML, NPM1-mutated AML, AML secondary to myeloproliferative neoplasms, and higher-risk myelodysplastic syndromes. The funded trials also address response assessment through minimal residual disease and remission depth in newly diagnosed and relapsed settings.
Clinical interest extends to treatment strategies for patients with limited sensitivity to intensive chemotherapy and to disease control in molecular relapse.
Fondazione Gimema Franco Mandelli Onlus runs clinical trials in conditions such as Acute myeloid leukaemia, Acute lymphocytic leukaemia, Chronic lymphocytic leukaemia, Chronic myeloid leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
ItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
